InvestorsHub Logo
Followers 64
Posts 6482
Boards Moderated 0
Alias Born 11/25/2007

Re: None

Monday, 02/04/2019 2:48:20 PM

Monday, February 04, 2019 2:48:20 PM

Post# of 39191
Annual Report was out on Jan 30

https://backend.otcmarkets.com/otcapi/company/financial-report/211235/content

Plan of Operation:
The Company had focused its acquisition and business development efforts in the homeopathic pharmaceuticals industry. The Company has produced an
inventory of its Emesyl® Nausea Relief homeopathic product for marketing
and sale. Emesyl® was invented by Dr. Charles Hensley, Ph.D., who had
created the Zicam® cold remedy. The Company offers Emesyl® Nausea Relief
for purchase at https://www.amazon.com/dp/B00U20H3KI and
www.Emesyl.com. The Company has also launched its Emesyl® Plus product,
which is its original nausea relief nasal spray with premium hemp oil. The Company is offering Emesyl® Plus for purchase at
https://www.amazon.com/dp/B07H2Z9BHS.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
The Company is presently focused on marketing its Emesyl® homeopathic
anti-nausea and its Emesyl® Plus products for retail sale. Presently, Emesyl® is available for sale at https://www.amazon.com/dp/B00U20H3KI and www.Emesyl.com, and Emesyl® Plus is available for sale at https://www.amazon.com/dp/B07H2Z9BHS. The Company is engaged in efforts
to expand all marketing and sales, as well as additional Emesyl®-branded
products.